Yahoo News: Volunteers needed for COVID-19 vaccine trial at UC
UC researchers join nationwide trial of Moderna vaccine
Yahoo News posted a story originated by WCPO-TV, Channel 9 on UC and UC Health joining a nationwide trial of the Moderna vaccine for COVID-19. Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases is the medical director of the trial at UC.
UC is one of 89 sites across the country taking part in the trial which is looking for a wide range of participants from the age of 18 and up, but researchers are trying to ensure that they have a diverse and representative study group here locally.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases/Photo/Joe Fuqua III/UC Creative + Brand
"We've been reaching out to community leaders in both the Latino and Hispanic communities," Fichtenbaum said. "We've also been reaching out to the African-American/Black community for the kinds of targets we're interested in, which is having about at least 30% of our study be from underrepresented populations so they have a chance to participate."
The first dose in the local study was administed at the UC College of Medicine on August 25, 2020.
Watch the full report here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Pocket-sized population threat
May 18, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
UC finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care
May 18, 2026
A University of Cincinnati primary care teaching clinic integrates substance use disorder treatment into resident training, expanding access to addiction care and boosting physician confidence.
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.